PDS Biotechnology Corp (PDSB): Total Assets
$30.49M
As of 2025-12-31
$8.81M
As of 2026-06-30
-26.6%
3-year compound annual growth
-0.3%
5-year compound annual growth
-13.8%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $30.49M | -32.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $45.36M | -23.6% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $59.39M | -22.9% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $77.01M | +14.6% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $67.20M | +117.5% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $30.89M | +113.2% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $14.49M | n/m | 2021-03-18, Balance as of period end |
| 2018-12-31 | $164.4K | -99.8% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $92.62M | -16.5% | 2019-02-21, Balance as of period end |
| 2016-12-31 | $110.91M | -17.3% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $134.09M | +696.0% | 2017-03-02, Balance as of period end |
| 2014-12-31 | $16.85M | n/a | 2016-03-08, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | $30.49M | -32.8% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $30.16M | -54.9% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $30.08M | -1.6% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $31.00M | +108.2% |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | $29.92M | -16.5% |
| Veru Inc. (VERU) | 2025-09-30 | $29.84M | -50.6% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Valion Bio, Inc. (VBIO) | 2025-12-31 | $31.61M | n/m |
| Nuvectis Pharma, Inc. (NVCT) | 2025-12-31 | $31.71M | +70.4% |
Compare PDSB, YARW, SBFM, CPHI side by side · Screen every company in Pharmaceutical Preparations ↗